arrow
A

An Liu

chinese research academy of environmental sciences
H指数:29
被引数:3,146

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of ainuovirine versus efavirenz combination therapies with lamivudine/tenofovir disoproxil fumarate for medication of treatment-naive HIV-1-positive adults: week 48 results of a randomized controlled phase 3 clinical trial followed by an open-label setting until week 96

艾诺韦林与依法韦仑联合治疗与拉米夫定/替诺福韦酯富马酸治疗初治HIV-1-positive成人药物的疗效和安全性: 48周随机对照3期临床试验的结果,随后开放标签设置,直到96周

2023-07-0111
OAAI
(5R)-5-hydroxytriptolide for HIV immunological non- responders receiving ART: a randomized, double-blinded, placebo-controlled phase II study

(5R)-5-羟基雷公藤内酯用于接受ART的HIV免疫无反应者: 一项随机,双盲,安慰剂对照的II期研究

2023-05-0111
OAAI
Multi-institutional validation of a radiomics-based artificial intelligence method for predicting response to PD-1/PD-L1 immune checkpoint inhibitor (ICI) therapy in stage IV NSCLC
2023-04-040
PRE
RADIOMICS-BASED MULTI-MODAL PREDICTION OF TREATMENT RESPONSE TO PD-1/PD-L1 IMMUNE CHECKPOINT INHIBITOR (ICI) THERAPY IN STAGE IV NON-SMALL CELL LUNG CARCINOMA (MNSCLC)
2022-11-070
OA